Lawyer profile
Taimi Jacobson
Latham & Watkins LLP
- Firm
- Latham & Watkins LLP
- Practice
- capital markets, corporate, life sciences capital markets
- Office
- Bay Area
- Active in the record
- 2020 to 2024
Deal experience
Deal types
Jurisdictions
Deals
8 announced deals in the record Latham & Watkins Advises Allogene Therapeutics in Pricing of US$110 Million Offering of Common Stock 17 May 2024
Latham & Watkins Advises on Rubrik, Inc.’s Upsized US$752 Million IPO 26 Apr 2024
Latham & Watkins Advises Revolution Medicines in its US$300.0 Million Public Offering of Common Stock 6 Mar 2023
Latham & Watkins advises Revolution Medicines in its US$230 Public OfferingMillion 20 Jul 2022
Latham & Watkins Advises Duolingo on IPO 28 Jul 2021
Latham & Watkins Advises Imago BioSciences on its Upsized Initial Public Offering 21 Jul 2021
Latham & Watkins advises the underwriters in Harpoon Therapeutics Public Offering 7 Jan 2021
Latham Advises the Underwriters in Silverback Therapeutics’ Initial Public Offering 4 Dec 2020
Deal alerts PRO
Get an email when Taimi Jacobson is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile